发明名称 MODIFIED RELEASE IBUPROFEN SOLID ORAL DOSAGE FORM
摘要 <p>A method for providing immediate and sustained release of ibuprofen to a subject, including administering, in a single dose, a modified release formulation of ibuprofen including a hydrophilic polymer, ibuprofen in solid dosage form uniformly dispersed in the polymer, and a dissolution additive and an inert formulation additive dispersed in the polymer. The hydrophilic polymer comprises a first hydroxypropyl methylcellulose (HPMC) having a viscosity of about 100 cps and a second HPMC having a viscosity between about 200 cps to about 50,000 cps. The solid dosage form is a monolithic tablet that demonstrates a mean ibuprofen plasma concentration in a subject greater than or equal to 6.4μg/ml within two hours of administration, and also demonstrates a mean ibuprofen plasma concentration in a subject greater than or equal to 6.4μg/ml for at least 8 hours after administration.</p>
申请公布号 EP2099433(A2) 申请公布日期 2009.09.16
申请号 EP20070862287 申请日期 2007.11.28
申请人 SCOLR PHARMA, INC. 发明人 HITE, MICHAEL;FEDERICI, CATHY;BRUNELLE, ALAN;TURNER, STEPHEN
分类号 A61K9/22;A61K9/16;A61K9/26;A61K31/192 主分类号 A61K9/22
代理机构 代理人
主权项
地址